GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

 1,775.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,812.50
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.92m
  • Volume: 2,848,451
  • Market Cap: £73,572m
  • RiskGrade: 129

GSK Overview

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.9% 0.0%
Div Cover n/a 2.6
Op Mrgn n/a 27.3%
ROCE n/a  
Latest F'cast
P/E 39.6 11.1
PEG n/a 4.0
Pr/Revenue 9.6 2.3
Pr/Book 5.3  
Latest F'cast
Revenue n/a 330.1%
PBT 7.7% 536.9%
EPS n/a 3.1%
DPS n/a 304.7%

GSK Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 33,754.00 6,221.00 123.90p 17.9 4.5 +4% 80.00p 3.6%
31-Dec-20 34,099.00 6,968.00 115.90p 14.5 n/a -6% 80.00p 4.8%
31-Dec-21 24,696.00 3,599.00 90.56p 22.2 n/a -22% 80.00p 4.0%
31-Dec-22 29,324.00 5,628.00 139.70p 10.3 0.2 +54% 44.00p 3.1%
31-Dec-23 30,328.00 6,064.00 155.10p 9.4 0.9 +11% 42.00p 2.9%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GSK Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 31,667.93 8,629.98 159.94p 11.1 3.6 +3% 60.71p 0.0%
31-Dec-25 33,633.08 9,702.17 176.43p 10.1 1.0 +10% 64.54p 0.0%
31-Dec-26 35,521.33 10,813.00 195.27p 9.1 0.9 +11% 68.86p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

GSK Company Announcements

Director/PDMR Shareholding 20-May-2024 15:30 RNS
GSK completes sale of shares in Haleon plc 17-May-2024 07:00 RNS
GSK announces intention to sell shares in Haleon 16-May-2024 16:42 RNS

GSK ShareCast News

London close: Stocks recoup some earlier losses 17-May-2024 ShareCast
GSK raises £1.25bn from sale of remaining Haleon... 17-May-2024 ShareCast
London close: Stocks mixed as ex-divs drag on FTSE 16-May-2024 ShareCast

GSK Top Newspaper Links

GSK sells remaining stake in Haleon for £1.2bn 17-May-2024 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent

Latest GSK Director Deals

Traded Action Notifier PriceAmountValue
16-May-24 Buy Dividends Hal Barron 3,542.25p 2,433 £86,183.04
16-May-24 Buy Dividends Hal Barron 4,488.00p 61 £2,737.68
10-May-24 Transfer From Julie Brown 0.000p 7 £0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GSK Market Data

Currency UK Pounds
Share Price 1,775.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,812.50
52 Week Low 1,316.00
Volume 2,848,451
Shares Issued 4,144.92m
Market Cap £73,572m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.05% below the market average69.05% below the market average69.05% below the market average69.05% below the market average69.05% below the market average
45.1% below the sector average45.1% below the sector average45.1% below the sector average45.1% below the sector average45.1% below the sector average
Price Trend
47.89% above the market average47.89% above the market average47.89% above the market average47.89% above the market average47.89% above the market average
62.96% above the sector average62.96% above the sector average62.96% above the sector average62.96% above the sector average62.96% above the sector average
Income
2.90% above the market average2.90% above the market average2.90% above the market average2.90% above the market average2.90% above the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
20.71% below the market average20.71% below the market average20.71% below the market average20.71% below the market average20.71% below the market average
29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 16-May-24 22-Feb-24
Paid 11-Jul-24 11-Apr-24
Amount 15.00p 16.00p

Trades for 20-May-2024

Time Volume / Share Price
15:58 3 @ 1,777.50p
15:55 6 @ 1,776.00p
16:35 1,789 @ 1,775.00p
16:35 1,344,270 @ 1,775.00p
16:35 668 @ 1,775.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page